Abstract 4102: N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer

吉西他滨 胰腺癌 医学 癌症 信使核糖核酸 癌症研究 内科学 肿瘤科 生物 生物化学 基因
作者
Ziming Chen
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (8_Supplement_1): 4102-4102
标识
DOI:10.1158/1538-7445.am2025-4102
摘要

Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with a 5-year survival rate of less than 10% and limited treatment options. Gemcitabine, a pyrimidine nucleoside analogue, is the standard first-line treatment for pancreatic cancer. However, drug resistance to gemcitabine remains a major challenge in PDAC. Dysregulation of N6-methyladenosine (m6A) modification has been linked to human disease regulation, and targeting aberrant m6A modifications or their key regulators may be beneficial to overcome drug resistance. However, the potential role and precise mechanism of m6A modification in the development of gemcitabine resistance in PDAC have not been fully elucidated. Methods: In this study, we screened gemcitabine-insensitive and -sensitive PDAC cells through exposure to time- and dose-gradient gemcitabine. We then performed m6A-sequencing analysis on these cells and identified the hyper-m6A modification of FZR1 as a key molecular event contributing to gemcitabine insensitivity in PDAC. Additionally, we examined human PDAC samples using m6A-qPCR assays and reaved that FZR1 m6A modification had a significant clinical PDAC diagnosis and therapeutic value for PDAC. Results: We found that PDAC cells with distinct gemcitabine sensitivity showed different m6A profiles and that FZR1 had the most upregulated m6A modification in gemcitabine-insensitive cells compared with gemcitabine-sensitive cells. Mechanistically, we discovered that RNA m6A modification enhanced FZR1 translation in a GEMIN5-dependent manner, leading to a gemcitabine-insensitive phenotype by inducing a quiescent state. Importantly, targeting the m6A modification of FZR1 increased the sensitivity of PDAC cells to gemcitabine both in vitro and in vivo. Conclusions: This study identified the m6A-FZR1 axis as an underlying mechanism contributing to gemcitabine treatment resistance in pancreatic cancer. The m6A-FZR1 axis may serve as a predictor of gemcitabine treatment response in patients with PDAC. Overall, our discoveries interestingly link the dysregulated m6A modification to gemcitabine insensitivity in PDAC, and provide new insights into the molecular mechanisms of gemcitabine resistance in this cancer type. Citation Format: Ziming Chen. N6-methyladenosine modification of FZR1 mRNA promotes gemcitabine resistance in pancreatic cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 4102.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研小白毅同学完成签到 ,获得积分10
1秒前
张长弓完成签到 ,获得积分10
1秒前
小鲨宇发布了新的文献求助10
2秒前
Lychee完成签到,获得积分10
2秒前
null的应助被waiting采纳,获得10
3秒前
小金人完成签到,获得积分10
3秒前
南瓜小笨111111完成签到 ,获得积分10
3秒前
小苦瓜完成签到,获得积分10
4秒前
4秒前
csz完成签到,获得积分10
5秒前
Candy完成签到 ,获得积分10
5秒前
JJD完成签到,获得积分10
5秒前
怕孤单的子默完成签到,获得积分10
6秒前
快乐小狗完成签到,获得积分10
6秒前
木心o完成签到,获得积分10
6秒前
雪霏完成签到 ,获得积分10
7秒前
7秒前
Mr.Ren完成签到,获得积分10
8秒前
hy完成签到,获得积分10
8秒前
Jonathan完成签到,获得积分10
9秒前
9秒前
Riley完成签到,获得积分10
10秒前
Crazy_Runner完成签到,获得积分10
11秒前
无花果的应助被快乐小狗采纳,获得10
12秒前
加贝完成签到,获得积分10
14秒前
复杂妙海完成签到,获得积分10
14秒前
踏实的水云完成签到,获得积分10
14秒前
科目三的应助被chemhub采纳,获得10
15秒前
GaoY完成签到,获得积分10
16秒前
Iris完成签到,获得积分10
16秒前
现实的傲薇完成签到,获得积分10
16秒前
16秒前
wq完成签到 ,获得积分10
17秒前
xhs12138完成签到,获得积分10
18秒前
18秒前
wuda完成签到,获得积分10
19秒前
xyj6486完成签到,获得积分10
19秒前
谨慎的佐罗完成签到,获得积分10
20秒前
20秒前
wanci的应助被加油的梨采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159131
求助须知:如何正确求助?哪些是违规求助? 9554607
关于积分的说明 21719828
捐赠科研通 7748795
什么是DOI,文献DOI怎么找? 3427149
关于科研通互助平台的介绍 2552079
邀请新用户注册赠送积分活动 2471428